Innovative Product Focus ATDBio specializes in high-quality, customized oligonucleotides, including highly modified and technically challenging sequences, making it a valuable partner for research institutions and biotech firms seeking advanced nucleic acid solutions.

Recent Acquisition The acquisition by Biotage enhances ATDBio’s global reach and product capabilities, opening opportunities for cross-selling and expanded market access in diagnostic and pharmaceutical sectors.

Research & Development Ongoing development of improved microbead technologies with funding from Innovate UK indicates a commitment to innovation, providing potential entry points for collaborations and new product offerings to high-throughput sequencing companies.

Market Presence Serving academia, biotech, and pharmaceutical industries with a focus on molecular diagnostics and research, ATDBio’s diverse customer base presents multiple avenues for expanding sales in emerging personalized medicine sectors.

Growth Potential With revenues between 1 million and 10 million dollars and a focus on advanced nucleic acid synthesis, there are growth opportunities through targeted outreach to research labs and companies focusing on next-generation sequencing and gene editing.